Back

Non-invasive thoracoabdominal mapping of post-oesophagectomy conduit function

Wang, T. H.-H.; Tokhi, A.; Gharibans, A.; Evennett, N.; Beban, G.; Schamberg, G.; Varghese, C.; Calder, S.; Duong, C.; O'Grady, G.

2023-01-11 surgery
10.1101/2023.01.10.23284370 medRxiv
Show abstract

IntroductionOesophagectomy is a complex procedure performed for malignant and benign conditions. Post-oesophagectomy conduit dysfunction is common, which can occur for several reasons including conduit dysmotility. However, reliable tools for evaluating conduit motility are lacking. A non-invasive device for gastric electrical mapping was recently developed to evaluate gastric electrical activity and function. This study aimed to assess the feasibility of BSGM in the post-oesophagectomy stomach. MethodsOesophagectomy patients from Auckland, New Zealand, were recruited. The Gastric Alimetry System(R) (New Zealand) was employed, comprising a stretchable array (8x8 electrodes), a wearable Reader, and validated iOS app for symptom logging. The protocol comprised a 30-minute baseline, a meal challenge, then 4 hours of post-prandial recordings. Analysis encompassed Principal Gastric Frequency, BMI-adjusted amplitude, Gastric Alimetry Rhythm Index (indicating rhythm stability), meal response, and symptoms. Adverse events were recorded. Results6 patients were recruited and gastric activity was successfully captured in all except one with the colonic interposition (negative control). Four patients showed abnormalities indicating post-operative gastric hypofunction: four with low or abnormal frequency (<2.65 cycles/min), three with low amplitude (<22V), two with low GA-RI (<0.25) and one with a reduced meal response. One patient had significant symptoms (nausea, early satiation) who demonstrated marked hypomotility in all four of these domains. No adverse events occurred. ConclusionGastric Alimetry is a safe and feasible technique to non-invasively assess gastric conduit motility following oesophagectomy. Parameters may need adjustment for post-surgical anatomy. Clinical studies assessing the role in diagnosis and therapy can be advanced.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 7%
20.7%
2
Neurogastroenterology & Motility
13 papers in training set
Top 0.1%
20.7%
3
Scientific Reports
3102 papers in training set
Top 26%
4.4%
4
Frontiers in Oncology
95 papers in training set
Top 1%
3.8%
5
Physiology & Behavior
30 papers in training set
Top 0.1%
3.8%
50% of probability mass above
6
American Journal of Gastroenterology
15 papers in training set
Top 0.1%
3.8%
7
Journal of Clinical Medicine
91 papers in training set
Top 2%
3.5%
8
eBioMedicine
130 papers in training set
Top 0.4%
3.3%
9
JMIR Research Protocols
18 papers in training set
Top 0.4%
2.6%
10
Biology Methods and Protocols
53 papers in training set
Top 0.5%
2.2%
11
Brain Communications
147 papers in training set
Top 1%
2.0%
12
npj Digital Medicine
97 papers in training set
Top 2%
1.8%
13
Frontiers in Physiology
93 papers in training set
Top 3%
1.8%
14
British Journal of Anaesthesia
14 papers in training set
Top 0.4%
1.8%
15
PLOS Computational Biology
1633 papers in training set
Top 17%
1.6%
16
BMC Neurology
12 papers in training set
Top 0.6%
1.2%
17
BMJ Paediatrics Open
21 papers in training set
Top 0.6%
1.0%
18
BMC Medical Informatics and Decision Making
39 papers in training set
Top 2%
0.8%
19
Frontiers in Medicine
113 papers in training set
Top 6%
0.8%
20
JMIR Formative Research
32 papers in training set
Top 1%
0.8%
21
Cancers
200 papers in training set
Top 4%
0.8%
22
American Journal of Physiology-Gastrointestinal and Liver Physiology
11 papers in training set
Top 0.2%
0.8%
23
Heliyon
146 papers in training set
Top 6%
0.8%
24
Annals of Biomedical Engineering
34 papers in training set
Top 1%
0.8%
25
Neurobiology of Disease
134 papers in training set
Top 4%
0.8%
26
Trials
25 papers in training set
Top 2%
0.7%
27
BMJ Open
554 papers in training set
Top 13%
0.7%
28
PLOS Digital Health
91 papers in training set
Top 3%
0.5%